Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Toffoli

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
JAMA Neurology|January 14, 2020
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled TrialStephen Mullin, Laura Smith, Katherine Lee, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 3, 2023
Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher DiseaseCornelis Blauwendraat, Nahid Tayebi, Elizabeth Geena Woo, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2026
Bridging Genetics and Precision Medicine in Parkinson's Disease through GP2Kajsa Atterling Brolin, Lara M Lange, Emily Navarro-Jones, et al.
Neurobiology of Disease|November 5, 2023
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI studyMarco Toffoli, Harneek Chohan, Stephen Mullin, et al.
Nature Medicine|April 20, 2026
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individualsElisa Menozzi, Yani Ren, Mallia Geiger, et al.
Neurology|June 28, 2020
<i>GBA</i> variants in REM sleep behavior disorder: A multicenter studyLynne Krohn, Jennifer A Ruskey, Uladzislau Rudakou, et al.
Neurobiology of Aging|May 16, 2020
SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorderUladzislau Rudakou, Naomi C Futhey, Lynne Krohn, et al.
Annals of Neurology|January 25, 2020
Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt SynucleinopathiesLynne Krohn, Richard Y J Wu, Karl Heilbron, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
JAMA Neurology|January 14, 2020
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled TrialStephen Mullin, Laura Smith, Katherine Lee, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 3, 2023
Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher DiseaseCornelis Blauwendraat, Nahid Tayebi, Elizabeth Geena Woo, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2026
Bridging Genetics and Precision Medicine in Parkinson's Disease through GP2Kajsa Atterling Brolin, Lara M Lange, Emily Navarro-Jones, et al.
Neurobiology of Disease|November 5, 2023
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI studyMarco Toffoli, Harneek Chohan, Stephen Mullin, et al.
Nature Medicine|April 20, 2026
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individualsElisa Menozzi, Yani Ren, Mallia Geiger, et al.
Neurology|June 28, 2020
<i>GBA</i> variants in REM sleep behavior disorder: A multicenter studyLynne Krohn, Jennifer A Ruskey, Uladzislau Rudakou, et al.
Neurobiology of Aging|May 16, 2020
SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorderUladzislau Rudakou, Naomi C Futhey, Lynne Krohn, et al.
Annals of Neurology|January 25, 2020
Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt SynucleinopathiesLynne Krohn, Richard Y J Wu, Karl Heilbron, et al.
Pageof 3